Subcutaneous C.E.R.A. for the Treatment of Chronic Renal Anemia in Predialysis Patients

BACKGROUND: We investigated the efficacy, safety and tolerability of once-monthly administration of C.E.R.A. in erythropoiesis stimulating agents (ESAs) naive predialysis patients with CKD for anemia treatment STUDY DESIGN: Single arm, open label study. METHODS: A total of 75 patients (mean (SD) age...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Balkan Med J
Main Authors: Üstündağ, Sedat, Doğan, Ekrem, Duranay, Murat, Kazancıoğlu, Rümeyza, Çelik, Vedat, Ünsal, Abdülkadir, Altıntepe, Lütfullah, Dursun, Belda, Akbaş, Ertuğrul, Özdener, Fatih, Yıldız, Alaattin
Format: Artigo
Jezik:Inglês
Izdano: AVES 2016
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4898992/
https://ncbi.nlm.nih.gov/pubmed/27308077
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5152/balkanmedj.2016.141173
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki